Odin Technologies aims to cut hospital costs and improve quality of life by
preventing the misdiagnosis of compartment syndrome; a complication that has proven
to be difficult for physicians to diagnose and monitor.
Compartment Syndrome is a condition that can occur in muscle
compartments after vascular damage. As the bleeding occurs, the compartment
pressure can increase to unsafe levels causing tissue ischemia. If not corrected with an
emergency fasciotomy, it can be life threatening for a patient.
Odin Technologies introduces the Valkyrie, a non-invasive optics-based tool
that can effectively monitor compartment pressure as it develops in a patient, in real
The ones who runs this company
CEO & Co-Founder
Steven received his Bachelor of Science degree
with an emphasis in Sports Medicine and Biology from Purdue University. Graduating as a Certified
Athletic Trainer, he gained a thorough understanding of common medical malpractice and
diagnostic procedure for compartment syndrome. Using his understanding of medicine, he
attended Northwestern University Pritzker School of Law, where he studied entrepreneurship law,
medical device regulation, and intellectual property law.
Thomas got his Bachelor of Science degree in Biology and
Chemistry from Purdue University. During his time at Purdue, he also received his MBA from the
Krannert School of Business. Currently, he is attending IUPUI as a candidate for a JD degree. For
Odin Technologies, Thomas specializes in finance, business, and legal strategy – working to get
Odin’s IP and regulatory strategy in order while implementing design control activities.
Takanori is currently a student at Rice University
pursuing a degree in biomedical engineering. He has had extensive experience in the design,
development, and fabrication of non-invasive diagnostic devices. With his explicit experience in
near-infrared spectroscopy and pulse-oximetry, he is working on the development of the high-
fidelity prototype of Odin’s product to be used in animal model and human testing.
Maham Rahimi, MD
Jonathan Gunn, JD, PhD
Payan Tabrizi, MD
September 2018 Odin Technologies is pursuing its first pre-clinical animal study with
Houston Methodist Research Institution.
June 2018 The Company got accepted into the TMCx medical device accelerator
program in Houston, Texas! The highly selective program is designed to promote
collaboration between companies and hospitals and begins in August, 2018.